NEW YORK (GenomeWeb News) – Luminex said after the close of the market on Monday that its fourth quarter revenues fell 1 percent year over year on lower assay sales.

Total revenues for the three months ended Dec. 31, 2013, were $55.2 million, down from $55.5 million in the fourth quarter of 2012. The results fell short of the consensus Wall Street estimate of $56.6 million in revenues for the quarter.

By segment, assays and related product revenue fell 25 percent to $19.5 million from $25.9 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

In Genome Biology this week: miRNAs linked to diffuse large B-cell lymphoma outcomes, database of bird genomes, and more.